A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus

Clinical Trial ID NCT00002095

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00002095

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med 1996 3.63
Next 100